Quantitative Cytochrome P450 3A4 Induction Risk Assessment Using Human Hepatocytes Complemented with Pregnane X Receptor-Activating Profiles
Drug Metabolism and Disposition · 2023-03 · 51 (3) · 276-284
DOI: 10.1124/dmd.122.001132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2023-03. Verfasst von Aynur Ekiciler und 6 weiteren Autor:innen. Beteiligte Einrichtung: Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland (A.E., A.P., M.D., N.P., K.U.) and Roche Pharm…. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Receptors, Steroid. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland (A.E., A.P., M.D., N.P., K.U.) and Roche Pharmaceutical Research and Early Development, China Innovation Center of R…
- kenichi.umehara@roche.com.
Zitieren
APA
Ekiciler, A., Chen, W. L. K., Bo, Y., Pugliano, A., Donzelli, M., Parrott, N., & Umehara, K. (2023). Quantitative Cytochrome P450 3A4 Induction Risk Assessment Using Human Hepatocytes Complemented with Pregnane X Receptor-Activating Profiles. Drug Metabolism and Disposition, 51(3), 276-284. https://doi.org/10.1124/dmd.122.001132
Vancouver
Ekiciler A, Chen WLK, Bo Y, Pugliano A, Donzelli M, Parrott N, et al. Quantitative Cytochrome P450 3A4 Induction Risk Assessment Using Human Hepatocytes Complemented with Pregnane X Receptor-Activating Profiles. Drug Metabolism and Disposition. 2023;51(3):276-284. doi:10.1124/dmd.122.001132
BibTeX
@article{Ekiciler2023,
author = {Ekiciler, Aynur and Chen, Wen Li Kelly and Bo, Yan and Pugliano, Alessandra and Donzelli, Massimiliano and Parrott, Neil and Umehara, Kenichi},
title = {Quantitative Cytochrome P450 3A4 Induction Risk Assessment Using Human Hepatocytes Complemented with Pregnane X Receptor-Activating Profiles},
journal = {Drug Metabolism and Disposition},
year = {2023},
volume = {51},
number = {3},
pages = {276--284},
doi = {10.1124/dmd.122.001132}
}
EUVIMED